Latest Articles
December 5, 2023
Addressing equity in exome sequencing: Proactive reanalysis through the Ambry Patient for Life program helps to reduce racial, ethnic, and ancestral disparities
Emerging evidence shows that exome sequencing outcomes can see similar racial and ethnic disparities as other genetic tests. Therefore, exome reanalysis represents a step to…
Genetic Discrimination
Hereditary Cancer
Whole Exome Sequencing
November 20, 2023
Guest Blog: The Importance of Family Health History
Genetic counselor Tawanna St. Lewis discusses the importance of family health history and genetic testing.
Family History
Genetic Testing
October 25, 2023
Off My Chest: How Negative Genetic Testing and a Supportive Community Helped Me Navigate Breast Cancer
Kristina O’Quinn shares her experience as a breast cancer survivor who underwent genetic testing to help inform her mastectomy choices.
Breast Cancer
Breast Cancer Awareness
Genetic Testing
October 18, 2023
Breast Cancer Awareness Month: CHEK2 with Petra Kleiblova and Zdenek Kleibl
Petra Kleiblova and Dr. Zdenek Kleib’s commentary on ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast…
BRCA1 & 2
Breast Cancer Awareness
CHEK2
October 17, 2023
Understanding Gene-Disease Validity in Breast Cancer: The Power of Evidence
An overview of gene-disease validity in the context of breast cancer, which affects approximately 1 in every 8 women.
Breast Cancer
Breast Cancer Awareness
Clinical Research
Genetic Testing
Novel Genes
September 27, 2023
Ambry Spotlight: BRCAResponder Amy Byer Shainman
Amy Byer Shainman, BRCAResponder, is a patient advocate, author, and producer who provides support and education related to having a pathogenic variant in BRCA1/2. Hear…
BRCA
BRCA1 & 2
Breast Cancer Awareness
Genetic Testing
Patient Advocate
Previvor
![overlay-bottom[1]](https://ambrygen.com/wp-content/uploads/2026/02/overlay-bottom1.svg)